Health ❯ Pharmaceuticals

Drug Approval

FDA FDA Regulations Clinical Trials Novo Nordisk Generic Drugs Sanofi Market Introduction Pain Management EU Regulations Rare Diseases FDA Drug Approval Sickle Cell Disease Treatment Regulatory Compliance Aifa Cancer Treatment Regulatory Affairs Transparency Weight Loss Drugs Ozempic Abortion Pills USFDA Mifepristone China Regulatory Concerns Epinephrine Hormonal Disorders Regulatory Process XPHOZAH Leucovorin Obesity Treatment Nonopioid Painkillers Nerve Damage

FDA Drug-Review Chief George Tidmarsh Resigns as HHS Probes Conduct

Aurinia has sued, alleging a personal vendetta that damaged its share price and included an attempted solicitation of payments.

FDA Names First 9 Drugs for ‘National Priority’ Fast-Track Reviews, Targeting 1–2-Month Decisions